Continuing Education Information

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Osteoarthritis Research Society International. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

View the Learner Notification HERE

Physicians (ACCME)

Amedco LLC designates this live activity for a maximum of 33.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

European Union Credit

ACCME carries reciprocity with EACCME which is for the European Union and covers most European countries, along with most international ones

Objectives - After Attending This Program You Should Be Able To:

1. Appreciate machine learning approaches in OA research.

2. Assimilate recent changes in management of OA

3. Understand risk factors for structural pathology and symptoms in OA

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit for individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement. 

Disclosures

Acknowledgement of Financial Commercial Support: No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support: No in-kind commercial support was received for this educational activity.

Relevant Financial Relationships: The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5)

All individuals in a position to control the content of CE are listed in the program book. If their name is not listed here, they disclosed that they had no financial relationships with a commercial interest.